DURHAM, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will represent Humacyte at the following conferences in September. H.C. Wainwright 26th Annual Global Investment Conference Format: Company Presentation Date: Tuesday, September 11, 2024 Time: 8:30 – 9 AM ET Webcast: https://journey.ct.events/view/ Cantor Global Healthcare Conference Format: Company Presentation Date: Wednesday, September 18,